G7X

ISPINESIB MESILATE


Toggle HydrogenToggle Labels

Chemical Component Summary

NameISPINESIB MESILATE
IdentifiersN-(3-azanylpropyl)-N-[(1R)-1-[7-chloranyl-4-oxidanylidene-3-(phenylmethyl)quinazolin-2-yl]-2-methyl-propyl]-4-methyl-benzamide
FormulaC30 H33 Cl N4 O2
Molecular Weight517.062
TypeNON-POLYMER
Isomeric SMILESCc1ccc(cc1)C(=O)N(CCCN)[C@@H](C2=Nc3cc(ccc3C(=O)N2Cc4ccccc4)Cl)C(C)C
InChIInChI=1S/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3/t27-/m1/s1
InChIKeyQJZRFPJCWMNVAV-HHHXNRCGSA-N

Chemical Details

Formal Charge0
Atom Count70
Chiral Atom Count1
Bond Count73
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB06188 
NameIspinesib
Groups investigational
Synonyms
  • Ispinesib Mesylate
  • Ispinesib
IndicationInvestigated for use/treatment in breast cancer, lung cancer, solid tumors, renal cell carcinoma, pediatric indications, ovarian cancer, and head and neck cancer.
Categories
  • Acids, Carbocyclic
  • Amides
  • Benzene Derivatives
  • Benzoates
  • Heterocyclic Compounds, Fused-Ring
CAS number336113-53-2

Related Resource References

Resource NameReference
Pharos CHEMBL228814
PubChem 6851740
ChEMBL CHEMBL228814
ChEBI CHEBI:94692